Extracellular Vesicles in Ophthalmology: From Natural Nanocarriers to Engineered Therapeutics
Bioengineering · 27.02.2026 · 13 (3) · 275
DOI: 10.3390/bioengineering13030275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 27.02.2026. Verfasst von Christopher Flores und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Connors BWH-MGB Collaborative IGNITE Award, NEI NIH HHS, The National Eye Institute.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are increasingly recognized as programmable bioactive carriers in non-viral gene delivery and adaptable bioengineering platforms. Beyond their roles as natural nanocarriers in intercellular communication, EVs can promote ocular surface repair and retinal neuroprotection with potential for low immunogenicity and high biocompatibility. Bioengineering now enables cargo encapsulation, surface targeting, and integration of EVs with biomaterial platforms to enhance tissue penetration, retention, and precision delivery. The emergence of induced pluripotent stem cell-derived EVs (iMSC-EVs) offers improved batch uniformity and potential for personalized therapy. However, progress hinges on resolving knowledge gaps in ocular EV biology, standardizing isolation and storage, scaling reproducible manufacturing, and executing focused clinical trials. We synthesize the current developments and outline how EVs are moving from biological mediators to engineered therapeutics to accelerate the translation of EV diagnostics and therapeutics for eye diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.
- Williams College, Williamstown, MA 01267, USA.
- Department of Biomedical Engineering, College of Engineering, University of Florida, Gainesville, FL 32611, USA.
- Mass General Brigham Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114, USA.
- North Texas Eye Research Institute, University of North Texas Health, Fort Worth, TX 76107, USA.
- College of Biomedical and Translational Sciences, University of North Texas Health, Fort Worth, TX 76107, USA.
ORCID-Profile: Lu Huang, Grace M Coyne, Brenna Hefley, Dimitrios Karamichos, Menglu Yang
Förderung
- Connors BWH-MGB Collaborative IGNITE Award
- NEI NIH HHS
- The National Eye Institute
Zitieren
APA
Flores, C., Mastantuono, F., Huang, L., McKay, T. B., Coyne, G. M., Hefley, B., Vasini, B., Karamichos, D., & Yang, M. (2026). Extracellular Vesicles in Ophthalmology: From Natural Nanocarriers to Engineered Therapeutics. Bioengineering, 13(3), 275. https://doi.org/10.3390/bioengineering13030275
Vancouver
Flores C, Mastantuono F, Huang L, McKay TB, Coyne GM, Hefley B, et al. Extracellular Vesicles in Ophthalmology: From Natural Nanocarriers to Engineered Therapeutics. Bioengineering. 2026;13(3):275. doi:10.3390/bioengineering13030275
BibTeX
@article{Flores2026,
author = {Flores, Christopher and Mastantuono, Fabiana and Huang, Lu and McKay, Tina B and Coyne, Grace M and Hefley, Brenna and Vasini, Brenda and Karamichos, Dimitrios and Yang, Menglu},
title = {Extracellular Vesicles in Ophthalmology: From Natural Nanocarriers to Engineered Therapeutics},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {3},
pages = {275},
doi = {10.3390/bioengineering13030275}
}
EUVIMED